BioSpace News Archive

Desktop Health, a healthcare business within Desktop Metal, Inc. (NYSE: DM) committed to developing 3D printing solutions for personalized medicine, today announced the commercial launch of the Einstein™ series, a high-precision family of 3D printers designed for dental professionals, and Flexcera™ Smile Ultra+, one of the strongest dental resins ever to receive FDA clearance for permanent use.

Stemson Therapeutics announced today the addition of Kapil Bharti, Ph.D. and George Murphy, M.D. to its Scientific Advisory Board (SAB).

Syner-G BioPharma Group, a leading provider of Chemistry, Manufacturing, and Controls technical, regulatory, and compliance consulting services to pharmaceutical and biotechnology clients, announced the acquisition of Impact Pharmaceutical Services.

Cystic fibrosis, a genetic lung disease affecting about 90,000 people worldwide, is most common within the white population, but it affects people of all races and ethnicities.

VySpine, a spine innovation leader using differentiated materials and designs, announced today that it has received 510(k) clearance from the FDA for the its ClariVy Cervical IBF System which is designed for use in anterior cervical discectomy with fusion (ACDF) procedures.

Texas Medical Technology, a leading manufacturer and distributor of medical supplies and equipment, announces a substantial investment in Olive Diagnostics, a medtech company transforming at-home urinalysis testing with a passive, continuous home monitoring system mounted on a toilet.

Eli Lilly and Company will participate in the Guggenheim Oncology Conference on Wednesday, Feb. 9, 2022.

SI-BONE, Inc. today announced it will report financial results for the fourth quarter and full year 2021 after market close on Monday, February 28, 2022.

Allakos Inc., a biotechnology company developing lirentelimab for the treatment of eosinophil and mast cell-related diseases, announced that it will host an Investor Day on February 15th starting at 8:00 am ET.

The Janssen Pharmaceutical Companies of Johnson & Johnson announced that 17 presentations will be featured at the 2022 American Society of Clinical Oncology Genitourinary Cancers Symposium, taking place in San Francisco and virtually from February 17-19.